CoChat

Ongoing Initiatives to Improve the Quality and Efficiency of Medicine Use within the Public Healthcare System in South Africa; A Preliminary Study

Open access
Meyer, Johanna C., Schellack, Natalie, Stokes, Jacobus, Lancaster, Ruth, Zeeman, Helecine, Defty, Douglas, Godman, Brian, Steel, Gavin · 2017 · Frontiers in Pharmacology
Cited by 175

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Introduction: South Africa has an appreciable burden of both communicable and non-communicable diseases as well as high maternal, neonatal and child morbidity. There have been significant strides with improving the public health system, and addressing current inequalities, in recent years with the right to health a constitutional provision in South Africa. Initiatives include the introduction of National Health Insurance (NHI), programmes to enhance access to medicines for patients with chronic diseases, as well as activities to improve care in hospitals including improving pharmacovigilance. Consequently, the objective of this paper is to review ongoing initiatives within the public healthcare sector in South Africa and their influence to provide future direction. Method: Principally a structured review of current and planned activities. Results: There have been a number of major activities and initiatives surrounding the availability and access to medicines in the public system in recent years in South Africa. This includes a National Surveillance Centre and an innovative early warning system for the supply of medicines as well as the development of a National Health Care Pricing Authority and initiatives to improve contracting. There have also been developments to improve the supply chain including instigating Medicine Procurement Units in the provinces and enhancing forecasting capabilities. Access to medicines is improving though the instigation of stable chronic disease management initiatives to increase the number of external pick-up points for medicines. There are also ongoing programmes to enhance adherence to medicines as well as enhance adherence to Standard Treatment Guidelines and Essential Medicines Lists with their increasing availability. In addition, there is a movement to enhance the role of health technology assessment in future decision making. Hospital initiatives include increased focus on reducing antimicrobial resistance through instigating stewardship programmes as well as improving adverse drug reaction reporting and associated activities. Conclusion: Overall, there are an appreciable number of ongoing activities within the public health system in South Africa to try and ensure and sustain universal healthcare. It is too early to assess their impact, which will be the subject of future research.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fphar.2017.00751

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 81

  1. Adebolu, 2014, Blood pressure control amongst patients living with hypertension presenting to an urban district hospital outpatient clinic in Kwazulu-Natal, Afr. J. Primary Health Care Fam. Med, 6, 572, 10.4102/phcfm.v6i1.572 · DOI
  2. Ally, 2015, Improving patient safety to antiretroviral treatment by actively soliciting adverse drug reaction reports, Afr. J. Phys. Health Educ. Recreation Dance Suppl., 2, 411
  3. Ampadu, 2016, Adverse drug reaction reporting in Africa and a comparison of individual case safety report characteristics between Africa and the rest of the world: analyses of spontaneous reports in VigiBase®, Drug Saf, 39, 335, 10.1007/s40264-015-0387-4 · DOI
  4. Awolola, 2014, Identification of over-compliant patients and pill dumpers with the ‘mixed’ pill count method and the impact of counselling or feedback on adherence to antiretroviral treatment, Afr. J. Phys. Health Educ. Recreation Dance. Suppl., 1, 105
  5. Baloyi, 2014, Loss to initiation on antiretroviral treatment (ART) after voluntary counselling and testing (VCT) at two VCT centres near Pretoria, South Africa, Afr. J. Phys. Health Educ. Recreation Dance Suppl., 1, 1
  6. Bester, Evaluating initial antimicrobial use in an adult intensive care unit at an Academic Teaching Hospital in Pretoria, South Africa, Afr. J. Phys. Act. Health Sci.
  7. Binagwaho, 2009, The role of social capital in successful adherence to antiretroviral therapy in Africa, PLoS Med., 6, e18, 10.1371/journal.pmed.1000018 · DOI
  8. Bjorkhem-Bergman, 2013, Interface management of pharmacotherapy. Joint hospital and primary care drug recommendations, Eur. J. Clin. Pharmacol, 69, 73, 10.1007/s00228-013-1497-5 · DOI
  9. Brink, 2016, Antimicrobial stewardship across 47 South African hospitals: an implementation study, Lancet Infect. Dis., 16, 1017, 10.1016/S1473-3099(16)30012-3 · DOI · Paper page
  10. Calhoun, 2008, Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research, Hypertension, 51, 1403, 10.1161/HYPERTENSIONAHA.108.189141 · DOI · Paper page
  11. Cois, 2015, Obesity trends and risk factors in the South African adult population, BMC obesity, 2, 42, 10.1186/s40608-015-0072-2 · DOI
  12. Costa, 2016, Implementation of clinical guidelines in Brazil: should academic detailing be used?, J. Pharm. Health Serv. Res, 7, 105, 10.1111/jphs.12133 · DOI
  13. 2012, Department of Health Republic of South Africa
  14. Dylst, 2013, Generic medicines: solutions for a sustainable drug market?, Appl. Health Econ. Health Policy, 11, 437, 10.1007/s40258-013-0043-z · DOI
  15. 2016, Competition and Applied Economics. Comments on select aspects of the NHI White Paper
  16. Eriksen, 2017, High adherence to the ‘Wise List’ treatment recommendations in Stockholm: a 15-year retrospective review of a multifaceted approach promoting rational use of medicines, BMJ Open, 7, e014345, 10.1136/bmjopen-2016-014345 · DOI
  17. Fullman, 2017, Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016, Lancet, 390, 1423, 10.1016/S0140-6736(17)32336-X · DOI · Paper page
  18. Gandra, 2014, Economic burden of antibiotic resistance: how much do we really know?, Clin. Microbiol. Infect, 20, 973, 10.1111/1469-0691.12798 · DOI · Paper page
  19. Godman, 2013, Personalizing health care: feasibility and future implications, BMC Med, 11, 179, 10.1186/1741-7015-11-179 · DOI
  20. Godman, 2014, Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications, Front. Pharmacol, 5, 106, 10.3389/fphar.2014.00106 · DOI
  21. Goff, 2017, Antibiotic stewardship hits a home run for patients, Lancet Infect. Dis., 17, 892, 10.1016/S1473-3099(17)30344-4 · doi:10.1016/s1473-3099(17)30344-4
  22. Gray, 2015, The relevance of systematic reviews on pharmaceutical policy to low- and middle-income countries, Int. J. Clin. Pharm, 37, 717, 10.1007/s11096-015-0156-6 · DOI
  23. Gray, 2015, Improving Health Systems Efficiency - South Africa
  24. Guerra-Junior, 2017, Health technology performance assessment: real-world evidence for public healthcare sustainability, Int. J. Technol. Assess. Health Care, 33, 279, 10.1017/S0266462317000423 · DOI
  25. Gustafsson, 2011, The ‘wise list’- a comprehensive concept to select, communicate and achieve adherence to recommendations of essential drugs in ambulatory care in Stockholm, Basic Clin. Pharm. Toxicol, 108, 224, 10.1111/j.1742-7843.2011.00682.x · DOI · Paper page
  26. Hoffman, 2015, INTRODUCTION: what will it take to address the global threat of antibiotic resistance?, J. Law Med. Ethics, 43, 6, 10.1111/jlme.12267 · DOI
  27. Jakovljevic, 2015, Growing burden of non-communicable diseases in the emerging health markets: the case of BRICS, Front. Public Health, 3, 65, 10.3389/fpubh.2015.00065 · DOI
  28. Jakovljevic, 2016, The New and Old Europe: east-west split in pharmaceutical spending, Front. Pharmacol, 7, 18, 10.3389/fphar.2016.00018 · doi:10.3389/fphar.2016.00018
  29. Jakovljevic, 2017, Evolving health expenditure landscape of the BRICS nations and projections to 2025, Health Econ, 26, 844, 10.1002/hec.3406 · DOI
  30. Kabudula, 2017, Progression of the epidemiological transition in a rural South African setting: findings from population surveillance in Agincourt, 1993–2013, BMC Public Health, 17, 424, 10.1186/s12889-017-4312-x · DOI · Paper page
  31. Kostic, 2017, Inflammatory Bowel Diseases (Crohn s Disease and Ulcerative Colitis): cost of treatment in serbia and the implications, Appl. Health Econ. Health Policy, 15, 85, 10.1007/s40258-016-0272-z · doi:10.1007/s40258-016-0272-z
  32. Krousel-Wood, 2004, Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients, Curr. Opin. Cardiol, 19, 357, 10.1097/01.hco.0000126978.03828.9e · DOI · Paper page
  33. Lalkhen, 2015, Multimorbidity in non-communicable diseases in South African primary healthcare, S. Afr. Med. J, 105, 134, 10.7196/SAMJ.8696 · DOI
  34. Lancaster, 2016, Improving access to health treatment guidelines through mobile technology, S. Afr. Pharm. J., 83, 42
  35. Leong, 2015, Selection of essential medicines in South Africa – a work in progress, S. Afr. Pharm. J., 82, 39
  36. Leopold, 2012, Differences in external price referencing in Europe: a descriptive overview, Health Policy, 104, 50, 10.1016/j.healthpol.2011.09.008 · doi:10.1016/j.healthpol.2011.09.008
  37. Lloyd-Sherlock, 2014, Hypertension among older adults in low- and middle-income countries: prevalence, awareness and control, Int. J. Epidemiol, 43, 116, 10.1093/ije/dyt215 · DOI · Paper page
  38. Magadzire, 2015, Improving access to medicines through centralised dispensing in the public sector: a case study of the Chronic Dispensing Unit in the Western Cape Province, South Africa, BMC Health Serv. Res, 15, 513, 10.1186/s12913-015-1164-x · DOI
  39. Malmstrom, 2013, Dabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs, Front. Pharmacol, 4, 39, 10.3389/fphar.2013.00039 · DOI
  40. Matlala, Knowledge and Attitudes among Healthcare Professionals to the Reporting of Adverse Drug Reactions at an Academic Hospital, South Africa, 26
  41. Matlala, Structure and activities of pharmacy and therapeutics committees among public hospitals in South Africa; findings and implications, Expert Rev. Clin. Pharmacol, 10, 1273, 10.1080/17512433.2017.1364625 · doi:10.1080/17512433.2017.1364625
  42. Matsitse, 2017, Compliance to the primary health care treatment guidelines and the essential medicines list in the management of sexually transmitted infections in correctional centres in South Africa: findings and implications, Expert Rev. Anti Infect. Ther., 5, 963, 10.1080/14787210.2017.1382354 · DOI
  43. Mehta, 2011, Pharmacovigilance: the devastating consequences of not thinking about adverse drug reactions. The burden of adverse drug reactions (ADRs) on patient care has been found to be high globally and is particularly high in South Africa, CME, 29, 247
  44. Mehta, 2014, Strengthening pharmacovigilance in South Africa, S. Afr. Med. J, 104, 104, 10.7196/samj.7517 · doi:10.7196/samj.7517
  45. Mendelson, 2015, The South African Antimicrobial Resistance Strategy Framework, 54
  46. Messina, 2017, Our collective contribution matters: Pharmacists unite in tackling antibiotic resistance for South Africa, S. Afr. Pharm. J., 84, 53
  47. Messina, 2015, antimicrobial stewardship with pharmacist intervention improves timeliness of antimicrobials across Thirty-three Hospitals in South Africa, Infect. Dis. Ther, 4, 5, 10.1007/s40121-015-0082-x · DOI
  48. Moosa, 2015, Knowledge of type-2 diabetes among patients attending a Community Health Centre in Pretoria, South Africa, Afr. J. Phys. Health Educ. Recreation Dance Suppl., 2, 241
  49. Moosa, 2016, Evaluation and management of patients referred to a tertiary-level hypertension clinic in Cape Town, South Africa, S. Afr. Med. J, 106, 797, 10.7196/SAMJ.2016.v106i8.9610 · DOI
  50. Mouton, 2015, Mortality from adverse drug reactions in adult medical inpatients at four hospitals in South Africa: a cross-sectional survey, Brit. J. Clin. Pharmacol, 80, 818, 10.1111/bcp.12567 · DOI
  51. Müller, 2016, Measuring adverse events using a trigger tool in a paper based patient information system at a teaching hospital in South Africa, Eur. J. Clin. Pharm, 18, 103
  52. Naidoo, 2014, High prevalence and incidence of sexually transmitted infections among women living in Kwazulu-Natal, South Africa, AIDS Res. Ther, 11, 31, 10.1186/1742-6405-11-31 · doi:10.1186/1742-6405-11-31
  53. 2017, Trends in obesity and diabetes across Africa from 1980 to 2014: an analysis of pooled population-based studies, Int. J. Epidemiol., 10.1093/ije/dyx078 · DOI · Paper page
  54. 2011, National Core Standards for Health Establishments in South Africa
  55. Republic of South Africa. Essential Drugs Programme. Hospital level (Adults) Standard Treatment Guidelines and Essential Medicines List
  56. Nielsen, 2017, Non-adherence to anti-hypertensive medication in low- and middle-income countries: a systematic review and meta-analysis of 92443 subjects, J. Hum. Hypertens, 31, 14, 10.1038/jhh.2016.31 · DOI · Paper page
  57. Norman, 2009, Potential savings without compromising the quality of care, Int. J. Clin. Pract, 63, 1320, 10.1111/j.1742-1241.2009.02129.x · DOI
  58. O'NeillJ. Securing New Drugs for Future Generations: The Pipeline of Antibiotics. The Review of Antimicrobial Resistance2015
  59. Parkinson, 2015, Disinvestment and value-based purchasing strategies for pharmaceuticals: an international review, Pharmacoeconomics, 33, 905, 10.1007/s40273-015-0293-8 · DOI · Paper page
  60. Paruk, 2012, Antibiotic prescription practices and their relationship to outcome in South Africa: findings of the prevalence of infection in South African intensive care units (PISA) study, S. Afr. Med. J, 102, 613, 10.7196/SAMJ.5833 · DOI
  61. Perumal-Pillay, 2016, Quantitative evaluation of essential medicines lists: the South African case study, BMC Health Serv. Res, 16, 687, 10.1186/s12913-016-1937-x · DOI
  62. Perumal-Pillay, Parents' and guardians' perceptions on availability and pricing of medicines and healthcare for children in eThekwini, South Africa - a qualitative study, BMC Health Serv. Res, 17, 417, 10.1186/s12913-017-2385-y · DOI
  63. Perumal-Pillay, Selection of essential medicines for South Africa - an analysis of in-depth interviews with national essential medicines list committee members, BMC Health Serv. Res, 17, 17, 10.1186/s12913-016-1946-9 · DOI
  64. Pharasi, 2012, Medicines Selection and Procurement in South Africa. SAHR 2012/, 2013, 177
  65. Pillay-van Wyk, 2016, Mortality trends and differentials in South Africa from 1997 to 2012: second National Burden of Disease Study, Lancet Global Health, 4, e642, 10.1016/S2214-109X(16)30113-9 · DOI · Paper page
  66. Putrik, Inequities in access to biologic and synthetic DMARDs across 46 European countries, Ann. Rheum. Dis., 73, 198, 10.1136/annrheumdis-2012-202603 · doi:10.1136/annrheumdis-2012-202603
  67. Putrik, Variations in criteria regulating treatment with reimbursed biologic DMARDs across European countries. Are differences related to country's wealth?, Ann. Rheum. Dis, 73, 2010, 10.1136/annrheumdis-2013-203819 · DOI
  68. Ramdas, 2015, Factors associated with retention in HIV care at Sediba Hope Medical Centre, South. Afr. J. HIV Med, 16, 1, 10.4102/sajhivmed.v16i1.347 · doi:10.4102/sajhivmed.v16i1.347
  69. Rampamba, 2017, Knowledge of hypertension and its management among hypertensive patients on chronic medicines at primary health care public sector facilities in South Africa; findings and implications, Expert Rev. Cardiovasc. Ther, 15, 639, 10.1080/14779072.2017.1356228 · DOI
  70. Schellack, 2017, Point Prevalence Survey of Antimicrobial Utilisation in an Academic Hospital in the Gauteng Province, South Africa, 7
  71. Schellack, 2016, Esprit de corps': Towards collaborative integration of pharmacists and nurses into antimicrobial stewardship programmes in South Africa, S. Afr. Med. J., 106, 973, 10.7196/SAMJ.2016.v106i10.11468 · doi:10.7196/samj.2016.v106i10.11468
  72. Sekhejane, 2013, South African National Health Insurance (NHI) Policy: Prospects and Challenges for its Efficient Implementation
  73. Sooruth, 2015, The use of Standard Treatment Guidelines and Essential Medicines List by professional nurses at primary healthcare clinics in the uMgungundlovu District in South Africa, Int. J. Afr. Nurs. Sci, 3, 50, 10.1016/j.ijans.2015.08.001 · doi:10.1016/j.ijans.2015.08.001
  74. Suleman, 2010, Pharmacovigilance – who is responsible and why should we care?, S. Afr. Pharm. J., 2010, 56
  75. Terblanche, Knowledge, attitudes and perspective on adverse drug reaction reporting in a public sector hospital in South Africa: baseline analysis, Hosp. Pract., 10.1080/21548331.2017.1381013 · doi:10.1080/21548331.2017.1381013
  76. Terblanche, Impact of a Pharmacist-Driven Pharmacovigilance System in a Secondary Hospital in the Gauteng Province of South Africa, 25
  77. Toit, 2017, Alternative models for delivery of medication to stable patients on long term therapy, S. Afr. Pharm. J., 84, 56
  78. Truter, 2017, Identifying medication errors in the neonatal intensive care unit and paediatric wards using a medication error checklist at a tertiary academic hospital in Gauteng, South Africa, S. Afr. J. Child Health, 11, 5, 10.7196/SAJCH.2017.v11i1.1101 · doi:10.7196/sajch.2017.v11i1.1101
  79. Vagiri, 2015, Health-related quality of life and adherence to antiretroviral treatment over a 12-month period for patients attending two public sector clinics in South Africa, Afr. J. Phys. Health Educ. Recreation Dance Suppl., 228
  80. Wang, Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015, Lancet HIV, 3, e361, 10.1016/S2352-3018(16)30087-X · DOI · Paper page
  81. Ware, 2009, Explaining adherence success in sub-Saharan Africa: an ethnographic study, PLoS Med, 6, e11, 10.1371/journal.pmed.1000011 · DOI · Paper page

Cited by

See all 175

Metadata

Authors
Meyer, J. C., Schellack, N., Stokes, J., Lancaster, R., Zeeman, H., Defty, D., Godman, B., & Steel, G.
Venue
Frontiers in Pharmacology
Published
2017-11-09
Volume
8
Pages
751-751
ISSN
1663-9812 (ISSN-L)
OpenAlex
W2762323838
Cited by
175
References
6
FWCI
30.27
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ongoing Initiatives to Improve the Quality and Efficiency of Medicine Use within the Public Healthcare System in South Africa; A Preliminary Study. https://app.cochat.ai/papers/10.3389/fphar.2017.00751
The paper
Meyer, J. C., Schellack, N., Stokes, J., Lancaster, R., Zeeman, H., Defty, D., Godman, B., & Steel, G. (2017). Ongoing Initiatives to Improve the Quality and Efficiency of Medicine Use within the Public Healthcare System in South Africa; A Preliminary Study. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2017.00751

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.